Eton Pharmaceuticals Announces Commercial Availability of Betaine Anhydrous for Oral Solution, a Generic Version of Cystadane® (betaine anhydrous for oral solution)
--
-- Product is now available exclusively through Optime Care --
“We are excited to be offering a lower cost alternative1 to Cystadane while still providing full patient and provider support services. We believe the adoption of our product will result in significant financial savings to the
Betaine Anhydrous is available exclusively through Optime Care, a specialty pharmacy dedicated to helping patients with rare diseases manage their conditions. Optime Care will administer the Eton Cares Program in partnership with
Clinicians seeking to prescribe Betaine Anhydrous can e-prescribe by selecting Optime Care as the pharmacy or fax in a patient referral form to 866-318-2990. Additional product details can be found on the product website, www.betaineus.com.
For questions regarding prescription fulfillment, please contact Optime Care at 1-888-673-0039.
1 https://www.analysource.com/products/active/ accessed
*Restrictions, limitations, and/or eligibility requirements may apply
Cystadane is a registered trademark of Recordati Orphan Drugs SAS
IMPORTANT SAFETY INFORMATION
Warnings and Precautions
Hypermethioninemia in Patients with CBS Deficiency: Betaine Anhydrous may worsen high methionine blood levels and accumulation of excess fluid in the brain has been reported. If you have been told you have
Adverse Reactions
Most common side effects were nausea and gastrointestinal distress, based on a survey of doctors. To report a suspected adverse event related to Betaine Anhydrous, contact
INDICATIONS AND USAGE
Betaine anhydrous for oral solution is indicated in children and adults for the treatment of homocystinuria to decrease high homocysteine blood levels. Homocystinuria is a rare genetic disorder in which there is an abnormal accumulation of the amino acid homocysteine in the blood and urine. The following are considered to be homocystinuria disorders:
- Cystathionine beta-synthase (CBS) deficiency
- 5,10-methylenetetrahydrofolate reductase (MTHFR) deficiency
- Cobalamin cofactor metabolism (cbl) defect
Please see full Prescribing Information for more information.
About
Investor Relations:
T: 212-452-2793
E: lwilson@insitecony.com
1406-v1

Source: Eton Pharmaceuticals